Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-27

Clinical Trial Update: Theta- and Alpha-Tuned Meditation for Negative Symptoms in Schizophrenia [NA]

View source ↗

Summary

A completed clinical trial investigating theta- and alpha-tuned meditation for negative symptoms in schizophrenia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Psychiatric Hospital of the Cross | Conditions: Schizophenia Disorder | NA | Status: COMPLETED